Verily

Verily Life Sciences, a subsidiary of Alphabet Inc., was founded in 2015 and focuses on research and precision health. The company leverages AI, data science, and technology to enhance health data utility, aiming for predictive, preventive, and precise healthcare solutions. Headquartered in South San Francisco, California, Verily integrates expertise from healthcare, engineering, and informatics to improve disease detection and management. Verily develops AI models and platforms for healthcare workflows, including multimodal data analytics and chronic care solutions. Their offerings include devices like continuous glucose monitors and smart wearables, as well as digital health solutions such as the Verily Me app for personalized health recommendations. The company also engages in research and analytics, collaborating on clinical trials and studies like Project Baseline. Verily's revenue is generated through product sales, partnerships, and research collaborations, supporting their mission to bridge the gap between research and care.